Stock Events

Stock Events

BNB Plus 

$0.4
0
+$0.02+5.4% Tuesday 20:00

Statistics

Day High
0.42
Day Low
0.37
52W High
14.25
52W Low
0.37
Volume
269,254
Avg. Volume
-
Mkt Cap
665,200
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-37.5
-25.23
-12.95
-0.68
Expected EPS
N/A
Actual EPS
N/A

Financials

-3,251.66%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.27MRevenue
-138.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNBX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap21.85B
Illumina provides sequencing and array-based solutions for genetic analysis, competing in the biotechnology and diagnostics sectors similar to APDN.
Qiagen NV
QGEN
Mkt Cap7.25B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with APDN's DNA-based technologies.
Pacific Biosciences of California
PACB
Mkt Cap378.93M
Pacific Biosciences offers sequencing systems that compete with APDN in the genomics and DNA sequencing markets.
Bio-Rad Laboratories
BIO
Mkt Cap7.7B
Bio-Rad Laboratories provides a range of products and systems used to separate complex chemical and biological materials, competing in the life sciences research and clinical diagnostics markets.
Thermo Fisher Scientific
TMO
Mkt Cap166.59B
Thermo Fisher Scientific offers a broad range of services and products, including analytical instruments and reagents, which compete with APDN's offerings in the life sciences sector.
Guardant Health
GH
Mkt Cap15.77B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with APDN in the molecular diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap485.93M
Fulgent Genetics provides comprehensive genetic testing solutions, competing with APDN in the DNA sequencing and genetic analysis market.
Adaptive Biotechnologies
ADPT
Mkt Cap2.22B
Adaptive Biotechnologies offers immune-driven medicine solutions, competing with APDN in the biotech sector focusing on genetic and molecular diagnostics.
CRISPR Therapeutics
CRSP
Mkt Cap4.86B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with the genetic technologies and services provided by APDN.

About

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Show more...
CEO
Mr. Clay D. Shorrock Esq., J.D.
Employees
46
Country
United States
ISIN
US03815U6073

Listings

F
DE
UDJ1.F
MU
DE
UDJ1.MU
XNAS
US
BNBX
STU
DE
UDJ1.STU

0 Comments

Share your thoughts

FAQ

What is BNB Plus stock price today?▼
The current price of BNBX is $0.4 USD — it has increased by +5.4% in the past 24 hours. Watch BNB Plus stock price performance more closely on the chart.
What is BNB Plus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BNB Plus stocks are traded under the ticker BNBX.
What is BNB Plus market cap?▼
Today BNB Plus has the market capitalization of 665,200
When is the next BNB Plus earnings date?▼
BNB Plus is going to release the next earnings report on August 06, 2026.
What were BNB Plus earnings last quarter?▼
BNBX earnings for the last quarter are -0.68 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BNB Plus revenue for the last year?▼
BNB Plus revenue for the last year amounts to 4.27M USD.
What is BNB Plus net income for the last year?▼
BNBX net income for the last year is -138.98M USD.
How many employees does BNB Plus have?▼
As of May 27, 2026, the company has 46 employees.
In which sector is BNB Plus located?▼
BNB Plus operates in the Health & Wellness sector.
When did BNB Plus complete a stock split?▼
The last stock split for BNB Plus was on June 02, 2025 with a ratio of 1:15.
Where is BNB Plus headquartered?▼
BNB Plus is headquartered in Stony Brook, United States.